Please use this identifier to cite or link to this item: http://imsear.hellis.org/handle/123456789/82745
Title: Patent ductus arteriosus in preterm neonates.
Authors: Agarwal, Ramesh
Deorari, Ashok K
Paul, Vinod K
Issue Date: 1-Mar-2008
Citation: Agarwal R, Deorari AK, Paul VK. Patent ductus arteriosus in preterm neonates. Indian Journal of Pediatrics. 2008 Mar; 75(3): 277-80
Abstract: Failure of the ductus arteriosus to close within 48-96 hours of postnatal age results in a left to right shunt across the ductus and overloading of the pulmonary circulation. This is more likely to happen in premature neonates with respiratory distress syndrome. Deterioration in the respiratory status on day 3-4 in a ventilated neonate and unexplained metabolic acidosis may be the earliest indicators of a patent ductus arteriosus (PDA). Indomethacin is the main stay of medical management of PDA in preterm neonates. Guidelines for administration of indomethacin have been described in the protocol. Restricted fluid therapy may be beneficial in the prevention of PDA in preterm neonates. Presence of PDA in a term neonate should be investigated to rule out an underlying congenital heart disease.
URI: http://imsear.hellis.org/handle/123456789/82745
Appears in Collections:Indian Journal of Pediatrics

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.